Purdue OTCs
This article was originally published in The Tan Sheet
Executive Summary
Stamford, Conn.-based firm announces resumed shipment of several OTC product lines after manufacturing difficulties, including Betadine microbicides, Colace stool softeners, Gentlax Tablets and Slow-Mag Tablets. "We are working hard to ensure that our full line of OTC products is back on the market and actively promoted as soon as possible, including the Senokot Laxative family of products," said Steve Seid, Exec Director-National Accounts & Trade Relations Feb. 22. Purdue acquired Colace and Slow-Mag last year to bolster consumer health business (1"The Tan Sheet" Jan. 6, 2003, p. 12)...
You may also be interested in...
Colace, Slow-Mag Buy Part Of Purdue Consumer Health Growth Plan
Purdue Pharma's acquisition of the Colace stool softener, Peri-Colace laxative capsule and Slow-Mag dietary supplement brands from Shire Pharmaceuticals Group is part of the firm's strategy to grow and diversify its consumer health business
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.